|
---|
Category:Letter
MONTHYEARULNRC-06853, Submittal of 2023 Fitness for Duty Performance Data Per Per 10 CFR 26.7172024-01-29029 January 2024 Submittal of 2023 Fitness for Duty Performance Data Per Per 10 CFR 26.717 IR 05000483/20230042024-01-19019 January 2024 Integrated Inspection Report 05000483/2023004 ML24008A0552024-01-19019 January 2024 Acceptance of Requested Licensing Action - Proposed Alternative to the Requirements of the ASME Code (EPID L-2023-LLR- 0061) ML23353A1712024-01-18018 January 2024 Issuance of Amendment No. 237 to Clarify Support System Requirements for the Residual Heat Removal System and Control Room Air Conditioning System Under Technical Specifications 3.4.8, 3.7.11, and 3.9.6 ML23317A0012024-01-12012 January 2024 Audit Summary Regarding LAR to Clarify Support System Requirements for the Residual Heat Removal and Control Room Air Conditioning System Under Technical Specifications 3.4.8, 3.7.11, and 3.9.6 ML23347A1212024-01-11011 January 2024 Issuance of Amendment No. 236 to Adopt TSTF-501, Revision 1, Relocate Stored Fuel Oil and Lube Volume Values to Licensee Control EPID L-2023-LLA-0046) ML24011A1492024-01-11011 January 2024 Notification of Post-Approval Site Inspection for License Renewal and Request for Information (05000483/2024011) ULNRC-06847, Supplement to Relief Request from Requirements of ASME BPV Code, Section XI, Subsection Iwl Regarding Examination and Testing of the Unbonded Post-Tensioning System (Relief Request C3R-01)2023-12-21021 December 2023 Supplement to Relief Request from Requirements of ASME BPV Code, Section XI, Subsection Iwl Regarding Examination and Testing of the Unbonded Post-Tensioning System (Relief Request C3R-01) ULNRC-06849, License Renewal Resolution for Commitments 34 and 35 Perform Evaluation of Crack Initiation and Propagation in Steam Generator Divider Plate and Tube-To-Tubesheet Welds2023-12-20020 December 2023 License Renewal Resolution for Commitments 34 and 35 Perform Evaluation of Crack Initiation and Propagation in Steam Generator Divider Plate and Tube-To-Tubesheet Welds ML23346A0392023-12-14014 December 2023 Supplemental Information Needed for Acceptance of Requested Licensing Action Request for Relief from Requirements of ASME Code, Section Xl, Examination and Testing Unbonded Post-Tensioning System ULNRC-06844, Request for Exemption from Specific Requirements in 2023 Security Rule, Enhanced Weapons, Firearms Background Checks, and Security Event Notification2023-12-0707 December 2023 Request for Exemption from Specific Requirements in 2023 Security Rule, Enhanced Weapons, Firearms Background Checks, and Security Event Notification 05000483/LER-2023-001, Submittal of LER 2023-001-00 for Callaway, Unit 1, Inoperable Instrument Tunnel Sump Level Indication Resulted in Condition Prohibited by Technical Specifications2023-11-29029 November 2023 Submittal of LER 2023-001-00 for Callaway, Unit 1, Inoperable Instrument Tunnel Sump Level Indication Resulted in Condition Prohibited by Technical Specifications ULNRC-06827, Supplement to License Amendment Request Regarding Support System Requirements for Residual Heat Removal and Control Room Air Conditioning Systems Under Technical Specifications 3.4.8, 3.7.11, and 3.9.6 (LDCN 22-0029)2023-11-20020 November 2023 Supplement to License Amendment Request Regarding Support System Requirements for Residual Heat Removal and Control Room Air Conditioning Systems Under Technical Specifications 3.4.8, 3.7.11, and 3.9.6 (LDCN 22-0029) IR 05000483/20230102023-11-15015 November 2023 NRC License Renewal Phase 1 Inspection Report 05000483 2023010 IR 05000483/20233012023-11-0909 November 2023 NRC Examination Report 05000483-2023301 ML23311A2082023-11-0909 November 2023 Reassignment of U.S. Nuclear Regulatory Commission Branch Chief in the Division of Operating Reactor Licensing for Plant Licensing Branch IV ML23297A2502023-11-0606 November 2023 Individual Notice of Consideration of Issuance of Amendment to Renewed Facility Operating License, Proposed No Significant Hazards Consideration Determination and Opportunity for a Hearing (EPID L-2022-LLA-0176) - Letter IR 05000483/20240122023-10-24024 October 2023 Information Request for the Cybersecurity Baseline Inspection, Notification to Perform Inspection (05000483/2024012) ML23293A2652023-10-24024 October 2023 3rd Quarter 2023 Integrated Inspection Report ML23240A3692023-10-0505 October 2023 Issuance of Amendment No. 235 to Revise Technical Specifications to Use of Framatome Gaia Fuel (EPID L-2022-LLA-0150) (Non-Proprietary) ML23234A1522023-10-0505 October 2023 Exemption from the Requirements of 10 CFR Part 50, Section 50.46, and Appendix K Regarding Use of M5 Cladding Material (EPID L-2022-LLE-0030) (Letter) ML23305A0942023-10-0202 October 2023 10-CW-2023-09 Post-Exam Submittal ML23270B9662023-09-27027 September 2023 10 CFR 50.55a(z)(I) Request for Relief from ASME OM Code Pump and Valve Testing Requirements for Fifth 120-Month Inservice Testing Interval ML23228A0252023-09-25025 September 2023 Issuance of Amendment No. 234 to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak Rate Test Frequencies ML23261C3852023-09-25025 September 2023 Safety Evaluation for Operating Quality Assurance Manual Revision 36A ML23166B0882023-09-20020 September 2023 Issuance of Amendment No. 233 for Adoption of Alternative Source Term and Revision of Technical Specifications ML23206A1992023-09-15015 September 2023 Regulatory Audit Summary Regarding License Amendment and Regulatory Exemptions Request for Fuel Transition to Framatome Gaia Fuel (Epids L-2022-LLA-0150 and L-2022-LLE-0030) IR 05000483/20234012023-09-13013 September 2023 NRC Security Baseline Inspection Report 05000483/2023401 ML23240A7572023-08-31031 August 2023 NRC Initial Operator Licensing Examination Approval 05000483/2023301 IR 05000483/20230052023-08-23023 August 2023 Updated Inspection Plan for Callaway Nuclear Power Plant, Unit 1 (Report 05000483/2023005) - Mid Cycle Letter 2023 ULNRC-06824, Response to Request for Additional Information Regarding Operating Quality Assurance Manual (Oqam) Revision 36A2023-08-17017 August 2023 Response to Request for Additional Information Regarding Operating Quality Assurance Manual (Oqam) Revision 36A ML23219A1392023-08-15015 August 2023 Request for Withholding Information from Public Disclosure ULNRC-06830, Transmittal of Updated Technical Specification Markup and Clean Pages for License Amendment Request to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak2023-08-15015 August 2023 Transmittal of Updated Technical Specification Markup and Clean Pages for License Amendment Request to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak ML23215A1972023-08-0303 August 2023 Supplement to License Amendment and Exemption Request Regarding Use of Framatome Gaia Fuel (LDCN 22-0002) ULNRC-06223, Minor Correction to License Amendment Request to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak Rate Test Frequencies (LDCN 2020-0004)2023-07-25025 July 2023 Minor Correction to License Amendment Request to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak Rate Test Frequencies (LDCN 2020-0004) ULNRC-06799, Submittal of Licensee Event Report 2022-003-01, Class 1E Electrical Air Conditioning System Thermal Expansion Valve Failure Resulted in Condition Prohibited by Technical Specifications2023-07-13013 July 2023 Submittal of Licensee Event Report 2022-003-01, Class 1E Electrical Air Conditioning System Thermal Expansion Valve Failure Resulted in Condition Prohibited by Technical Specifications IR 05000483/20230022023-07-10010 July 2023 Integrated Inspection Report 05000483/2023002 ML23174A1272023-06-23023 June 2023 Cw FFD Document Request List 2023 ML23171A9942023-06-22022 June 2023 Acceptance of Request for Approval of Operating Quality Assurance Manual Revision 36a ULNRC-06821, Post-Audit Follow-Up Information in Support of Callaway'S License Amendment Request and Proposed Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (EPID L-2022-LLA-0150 and EPID L-2022-LLE-00301)2023-06-21021 June 2023 Post-Audit Follow-Up Information in Support of Callaway'S License Amendment Request and Proposed Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (EPID L-2022-LLA-0150 and EPID L-2022-LLE-00301) IR 05000483/20230112023-06-15015 June 2023 Comprehensive Engineering Team Inspection (CETI) Inspection Report 05000483/2023011 ULNRC-06822, Additional Information Regarding Request for NRC Approval of Operating Quality Assurance Manual (Oqam) Revision 36a2023-06-14014 June 2023 Additional Information Regarding Request for NRC Approval of Operating Quality Assurance Manual (Oqam) Revision 36a ML23158A1462023-06-13013 June 2023 Notification of Post-Approval Site Inspection for License Renewal and Request for Information Inspection (05000483/2023010) ULNRC-06815, Request for NRC Approval of Operating Quality Assurance Manual, Revision 36a2023-06-0505 June 2023 Request for NRC Approval of Operating Quality Assurance Manual, Revision 36a ULNRC-06818, Response to Request for Additional Information Regarding License Amendment Request to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak Rate .2023-06-0505 June 2023 Response to Request for Additional Information Regarding License Amendment Request to Revise Technical Specification 5.5.16, Containment Leakage Rate Testing Program, for Permanent Extension of Type a and Type C Leak Rate . ML23093A0952023-05-10010 May 2023 Issuance of Amendment No. 232 Regarding Technical Specification Changes for Spent Fuel Storage ULNRC-06816, Withdrawal of Previously Submitted Enclosures Regarding License Amendment Request for Adoption of Alternative Source Term and Revision of Technical Specifications (LDCN 21-0015)2023-05-0909 May 2023 Withdrawal of Previously Submitted Enclosures Regarding License Amendment Request for Adoption of Alternative Source Term and Revision of Technical Specifications (LDCN 21-0015) ML23129A7942023-05-0909 May 2023 Post-Audit Supplement to License Amendment Request and Exemption to Allow Use of Framatome Gaia Fuel (LDCN 22-0002) (Iepid L-2022-LLA-0150 and EPID L-2022-LLE-0030) ML23122A3172023-05-0808 May 2023 Review of the Spring 2022 Steam Generator Tube Inservice Inspections ML23118A3492023-05-0808 May 2023 Request for Withholding Information from Public Disclosure 2024-01-29
[Table view] Category:Report
MONTHYEARML23354A2462023-12-20020 December 2023 Cracking Assessment for Framatome RSG Channel Head Assembly ML23215A1992023-08-31031 August 2023 ANP-4012NP, Callaway, Unit 1, Rod Ejection Accident Analysis Revision 2, August 2023 ML23299A1982023-06-16016 June 2023 Enclosure 2: Callaway RR Tech Report Containment Post-Tensioning System Inservice Inspection Technical Report Basis for Proposed Extension of Examination Interval, Revision 0 ML23156A6712023-06-0505 June 2023 Description and Justification for Changes ML23150A1832023-05-30030 May 2023 EIP-ZZ-00240 Addendum E, Revision 027, Health Physics Coordinator (Hpc) Checklist Administrative Correction ML23150A1842023-05-18018 May 2023 EIP-ZZ-00240 Addendum E, Revision 027, Health Physics Coordinator (Hpc) Checklist ML23150A1892023-05-18018 May 2023 EIP-ZZ-00245 Addendum H, Revision 004, Security Coordinator Checklist for the Alternate Tsc/Osa Assembly Area ML23131A3882023-04-26026 April 2023 EIP-ZZ-PRO2O Minor Revision 54, Activation and Operation of the Joint Information Center - Procedure Review Form and 50.54(q) Screening Form ML23110A0712023-04-0606 April 2023 Procedure Review Form (PRF) for EIP-ZZ-A0066, Revision 28, RERP Training Program ML23068A0992023-03-0909 March 2023 Special Report 2023-01 PAM Report ML23052A0492023-02-14014 February 2023 Enclosure 7 - Holtec International Report HI-2230125, Revision 0, Supplemental Criticality Safety Analysis of SFP for Callaway Nuclear Generating Station, Revision 0, Dated February 14, 2023 ML22349A6272022-12-15015 December 2022 Enclosure 3 - 2022 Proxy Statement of Ameren Corporation ML22349A6322022-12-15015 December 2022 Enclosure 8 - 10-K Filed 02/23/2022 ML22349A6342022-12-15015 December 2022 Enclosure 9 - 10-Q Filed 03/31/2022 ML22349A6352022-12-15015 December 2022 Enclosure 10 - 10-Q Filed 06/30/2022 ML22349A6362022-12-15015 December 2022 Enclosure 11 - 10-Q Filed 09/30/2022 ML22349A6402022-12-15015 December 2022 Enclosure 14 - Schedule 14C Information for Union Electric Company March 2022 ML22327A2242022-11-23023 November 2022 Enclosure 1: Callaway Plant - Report Period: 10 CFR 50.59 and 10 CFR 72.48 Summary Report June 16, 2021 to November 23, 2022 ML22335A5012022-11-16016 November 2022 Enclosure 3: ANP-4012NP, Revision 1, Callaway Rod Ejection Accident Analysis ML22318A1902022-11-14014 November 2022 Enclosure 2 - Pressurized Water Reactor Owners Group Letter, OG-22-187, Subject: PWR Owners Group Mode 4 LOCA Analysis for Westinghouse NSSS Plants ML22299A2352022-10-21021 October 2022 HI-2220020, Revision 2, Non Proprietary Version of Criticality Safety Analysis of SFP for Callaway Nuclear Generating Station ML22285A1252022-10-12012 October 2022 Attachment 8 to Enclosure 1: ANP-3969NP, Callaway Non-LOCA Summary Report, Revision 2, Dated October 2022 ML22285A1222022-10-12012 October 2022 Attachment 5 to Enclosure 1: ANP-3947NP, Callaway Unit 1 License Amendment Request Inputs for Use of Framatome Fuel, Revision 3, Dated October 2022 ML22285A1232022-10-12012 October 2022 Attachment 6 to Enclosure 1: ANP-3944NP, Callaway Realistic Large Break LOCA Analysis with Gaia Fuel Design, Revision 1, Dated October 2022 ML22285A1242022-10-12012 October 2022 Attachment 7 to Enclosure 1: ANP-3943NP, Callaway Small Break LOCA Analysis with Gaia Fuel Design, Revision 1, Dated October 2022 ML22181B1362022-06-30030 June 2022 Attachment 6 - Replacement for Attachment 6, Description and Assessment Specific to TSTF-439, of ULNRC-06688 ML22181B1402022-06-30030 June 2022 Enclosure 1 - Replacement for Enclosure 1, List of Revised Required Actions to Corresponding PRA Functions, of ULNRC-06688 ML22181B1412022-06-30030 June 2022 Enclosure 4 - Replacement for Enclosure 4, Information Supporting Justification of Excluding Sources of Risk Not Addressed by the PRA Models, of ULNRC-06688 ML22153A1822022-06-0202 June 2022 Attachment 6 - Non-Proprietary Version of Rlbloca Summary Report ML22153A1832022-06-0202 June 2022 Attachment 7 - Non-Proprietary Version of SBLOCA Summary Report ML22153A1852022-06-0202 June 2022 Attachment 8 - Non-Proprietary Version of Non-LOCA Summary Report ULNRC-06715, Enclosure 3: Attachment a to the NPDES Permit Modification Application2022-03-0101 March 2022 Enclosure 3: Attachment a to the NPDES Permit Modification Application ML22027A8092022-01-27027 January 2022 Enclosure 4: Callaway, Unit 1, Acronyms and Definitions ML22027A8082022-01-27027 January 2022 Enclosure 3: Callaway, Unit 1, Methodology for a Risk-Informed Approach to Address Generic Letter 2004-02 ML22027A8062022-01-27027 January 2022 Enclosure 1: Request for Exemptions for Risk-Informed Approach to Resolution for Generic Letter 2004-02 ML21356B5072021-12-22022 December 2021 Enclosure 1: Mark-up of Operating License (OL) ML21356B5082021-12-22022 December 2021 Enclosure 2: Clean Copy of Affected OL Pages (Reflecting Proposed Change) ML21343A0952021-12-0909 December 2021 Attachment 1: Description and Assessment ML21335A1602021-12-0101 December 2021 Special Report 2021-02: Accident Monitoring Instrumentation Non-Functional for Greater than 7 Days ML21280A3802021-10-0707 October 2021 Cumulative Summary of Changes to Enclosure 2, License Amendment Request, and Enclosure 3, Callaway Methodology for a Risk-Informed Approach to Address Generic Letter 2004-02, of ULNRC-06526 ML21280A3812021-10-0707 October 2021 License Amendment Request for Risk-Informed Approach to Resolution of Generic Letter 2004-02 ML21272A1702021-09-28028 September 2021 Enclosure 2 - Full Scope Implementation of Alternative Source Term Evaluation of Proposed Changes (Redacted) ML21237A1372021-08-23023 August 2021 Enclosure 1: Callaway, Unit 1, Amendment Request Regarding Risk-Informed Approach to Closure of Generic Safety Issue 191 - Baseline Weld Input ML21237A1382021-08-23023 August 2021 Enclosure 2: Callaway, Unit 1, Amendment Request Regarding Risk-Informed Approach to Closure of Generic Safety Issue 191 - CAL Roverd Results Baseline (Critical Breaks) ULNRC-06683, Enclosure 3: Callaway, Unit 1, Amendment Request Regarding Risk-Informed Approach to Closure of Generic Safety Issue 191 - CAL Roverd Results Baseline (Non-Isolable Breaks)2021-08-23023 August 2021 Enclosure 3: Callaway, Unit 1, Amendment Request Regarding Risk-Informed Approach to Closure of Generic Safety Issue 191 - CAL Roverd Results Baseline (Non-Isolable Breaks) ULNRC-06526, Methodology for a Risk-Informed Approach to Address Generic Letter 2004-022021-07-22022 July 2021 Methodology for a Risk-Informed Approach to Address Generic Letter 2004-02 ULNRC-06660, Cycle 24 Commitment Change Summary Report2021-06-22022 June 2021 Cycle 24 Commitment Change Summary Report ML21173A3412021-06-22022 June 2021 CFR 50.59 and 10 CFR 72.48 Summary Report - May 16, 2019 to June 15, 2021 ML21090A2502021-03-31031 March 2021 Attachment 1 - Changes to the Westinghouse ECCS Evaluation Model and PCT Penalty Assessments ML21090A1882021-03-31031 March 2021 Enclosure 3 - Callaway Methodology for a Risk-Informed Approach to Address Generic Letter 2004-02 2023-08-31
[Table view] Category:Miscellaneous
MONTHYEARML23156A6712023-06-0505 June 2023 Description and Justification for Changes ML23131A3882023-04-26026 April 2023 EIP-ZZ-PRO2O Minor Revision 54, Activation and Operation of the Joint Information Center - Procedure Review Form and 50.54(q) Screening Form ML23068A0992023-03-0909 March 2023 Special Report 2023-01 PAM Report ULNRC-06715, Enclosure 3: Attachment a to the NPDES Permit Modification Application2022-03-0101 March 2022 Enclosure 3: Attachment a to the NPDES Permit Modification Application ML22027A8062022-01-27027 January 2022 Enclosure 1: Request for Exemptions for Risk-Informed Approach to Resolution for Generic Letter 2004-02 ML22027A8092022-01-27027 January 2022 Enclosure 4: Callaway, Unit 1, Acronyms and Definitions ML21356B5072021-12-22022 December 2021 Enclosure 1: Mark-up of Operating License (OL) ML21356B5082021-12-22022 December 2021 Enclosure 2: Clean Copy of Affected OL Pages (Reflecting Proposed Change) ML21343A0952021-12-0909 December 2021 Attachment 1: Description and Assessment ML21335A1602021-12-0101 December 2021 Special Report 2021-02: Accident Monitoring Instrumentation Non-Functional for Greater than 7 Days ML21280A3802021-10-0707 October 2021 Cumulative Summary of Changes to Enclosure 2, License Amendment Request, and Enclosure 3, Callaway Methodology for a Risk-Informed Approach to Address Generic Letter 2004-02, of ULNRC-06526 ML21280A3812021-10-0707 October 2021 License Amendment Request for Risk-Informed Approach to Resolution of Generic Letter 2004-02 ML21173A3412021-06-22022 June 2021 CFR 50.59 and 10 CFR 72.48 Summary Report - May 16, 2019 to June 15, 2021 ULNRC-06437, Cycle 22 Commitment Change Summary Report2018-06-0707 June 2018 Cycle 22 Commitment Change Summary Report ULNRC-06349, Callaway, Unit 1 - Enclosure 2 to ULNRC-06349 - Minimum Decommissioning Cost - Per 10 CFR 50.75 Formula Process2017-03-30030 March 2017 Callaway, Unit 1 - Enclosure 2 to ULNRC-06349 - Minimum Decommissioning Cost - Per 10 CFR 50.75 Formula Process ML17097A5582017-03-30030 March 2017 Enclosure 2 to ULNRC-06349 - Minimum Decommissioning Cost - Per 10 CFR 50.75 Formula Process ML16160A0952016-06-0808 June 2016 ASP ANALYSIS-REJECT- Callaway Unit 1 Auxiliary Feedwater Control Valves in Motor Driven Pump Train Inoperable due to Faulty Electric positioner Cards (LER 483-2015-003 and 483-2015-004) ULNRC-06292, Transmittal of 10 CFR50.46 Annual Report ECCS Evaluation Model Revisions2016-03-30030 March 2016 Transmittal of 10 CFR50.46 Annual Report ECCS Evaluation Model Revisions ULNRC-06199, Nuclear Property Insurance Reporting2015-03-18018 March 2015 Nuclear Property Insurance Reporting ULNRC-06173, Submits Owner'S Activity Reports (OAR-1 Forms) for Cycle 20 and Refuel 202015-02-19019 February 2015 Submits Owner'S Activity Reports (OAR-1 Forms) for Cycle 20 and Refuel 20 ML14310A8362015-02-0909 February 2015 NRC Staff Evaluation of Final Rule for Continued Storage of Spent Nuclear Fuel for the License Renewal Environmental Review for Callaway, Unit 1 ULNRC-06168, Enclosure 10 - Articles of Incorporation Ameren Corporation Restated 10/17/19952014-12-18018 December 2014 Enclosure 10 - Articles of Incorporation Ameren Corporation Restated 10/17/1995 ULNRC-06168, Enclosure 7 - 10-Q Filed Period 6/30/2014 Ameren2014-12-18018 December 2014 Enclosure 7 - 10-Q Filed Period 6/30/2014 Ameren ULNRC-06168, Enclosure 16 - Articles of Incorporation - Union Electric Company Restated 04/12/19942014-12-18018 December 2014 Enclosure 16 - Articles of Incorporation - Union Electric Company Restated 04/12/1994 ULNRC-06168, Enclosure 5 - 10-K Filed Period 12/31/2013 - Ameren2014-12-18018 December 2014 Enclosure 5 - 10-K Filed Period 12/31/2013 - Ameren ULNRC-06168, Enclosure 8 - 10-Q Filed Period 9/30/2014 Ameren2014-12-18018 December 2014 Enclosure 8 - 10-Q Filed Period 9/30/2014 Ameren ULNRC-06168, Enclosure 9 - Articles of Incorporation Ameren Corporation Dated 08/07/19952014-12-18018 December 2014 Enclosure 9 - Articles of Incorporation Ameren Corporation Dated 08/07/1995 ULNRC-06168, Enclosure 14 - Defc 14c Filed Period 3/11/2014 - Union Electric2014-12-18018 December 2014 Enclosure 14 - Defc 14c Filed Period 3/11/2014 - Union Electric ULNRC-06168, Enclosure 6 - 10-Q Filed Period 3/31/2014 - Ameren2014-12-18018 December 2014 Enclosure 6 - 10-Q Filed Period 3/31/2014 - Ameren ULNRC-06168, Enclosure 11 - Ameren Corporation By-Laws Effective 12/14/20122014-12-18018 December 2014 Enclosure 11 - Ameren Corporation By-Laws Effective 12/14/2012 ULNRC-06168, Enclosure 15 - Articles of Incorporation - Missouri Electric Light and Power Company Dated 11/20/19222014-12-18018 December 2014 Enclosure 15 - Articles of Incorporation - Missouri Electric Light and Power Company Dated 11/20/1922 ULNRC-06168, Enclosure 4 - 2013 Annual Report (Includes 2013 Form 10-K) - Ameren2014-12-18018 December 2014 Enclosure 4 - 2013 Annual Report (Includes 2013 Form 10-K) - Ameren ULNRC-06168, Enclosure 17 - By-Laws of Union Electric Company as Amended to 12/10/20102014-12-18018 December 2014 Enclosure 17 - By-Laws of Union Electric Company as Amended to 12/10/2010 ML14352A4292014-12-18018 December 2014 Enclosure 15 - Articles of Incorporation - Missouri Electric Light and Power Company Dated 11/20/1922 ML14352A4302014-12-18018 December 2014 Enclosure 17 - By-Laws of Union Electric Company as Amended to 12/10/2010 ML14352A4472014-12-18018 December 2014 Enclosure 3 - 2014 Proxy Statement of Ameren Corporation - Ameren ML14352A4322014-12-18018 December 2014 Enclosure 16 - Articles of Incorporation - Union Electric Company Restated 04/12/1994 ML14352A4332014-12-18018 December 2014 Enclosure 4 - 2013 Annual Report (Includes 2013 Form 10-K) - Ameren ML14352A4342014-12-18018 December 2014 Enclosure 11 - Ameren Corporation By-Laws Effective 12/14/2012 ML14352A4352014-12-18018 December 2014 Enclosure 6 - 10-Q Filed Period 3/31/2014 - Ameren ML14352A4362014-12-18018 December 2014 Enclosure 14 - Defc 14c Filed Period 3/11/2014 - Union Electric ML14352A4382014-12-18018 December 2014 Enclosure 9 - Articles of Incorporation Ameren Corporation Dated 08/07/1995 ML14352A4392014-12-18018 December 2014 Enclosure 8 - 10-Q Filed Period 9/30/2014 Ameren ML14352A4402014-12-18018 December 2014 Enclosure 5 - 10-K Filed Period 12/31/2013 - Ameren ML14352A4412014-12-18018 December 2014 Enclosure 7 - 10-Q Filed Period 6/30/2014 Ameren ML14352A4432014-12-18018 December 2014 Enclosure 10 - Articles of Incorporation Ameren Corporation Restated 10/17/1995 ULNRC-06157, Special Report 2014-04: Inoperability of a Seismic Instrument for Greater than 30 Days2014-11-14014 November 2014 Special Report 2014-04: Inoperability of a Seismic Instrument for Greater than 30 Days ML14290A5322014-10-29029 October 2014 Staff Assessment of Response to 10 CFR 50.54(f) Information Request - Flood -Causing Mechanism Reevaluation ULNRC-06139, Special Report 2014-01 - PAM Report Inoperability of a Post Accident Monitoring (PAM) Instrument2014-09-0202 September 2014 Special Report 2014-01 - PAM Report Inoperability of a Post Accident Monitoring (PAM) Instrument RIS 2014-07, Regulatory Issue Summary (RIS) 2014-07, Enhancements to the Vendor Inspection Program- Vendor Information Request. Part 1 of 52014-06-19019 June 2014 Regulatory Issue Summary (RIS) 2014-07, Enhancements to the Vendor Inspection Program- Vendor Information Request. Part 1 of 5, Regulatory Issue Summary (RIS) 2014-07, Enhancements to the Vendor Inspection Program- Vendor Information Request. Part 2 of 5, Regulatory Issue Summary (RIS) 2014-07, Enhancements to the Vendor Inspection Program- Vendor Information Request. Part 3 of 5, Regulatory Issue Summary (RIS) 2014-07, Enhancements to the Vendor Inspection Program- Vendor Information Request. Part 4 of 5, Regulatory Issue Summary (RIS) 2014-07, Enhancements to the Vendor Inspection Program- Vendor Information Request. Part 5 of 5 2023-06-05
[Table view] |
Text
wAmeren UE AmerenUE Cal/away Plant July 26, 2010 ULNRC-05720 u.s. Nuclear Regulatory Commission Attn: Document Control Desk Washington, DC 20555-0001 Ladies and Gentlemen:
10CFR26.719(c)
DOCKET NUMBER 50-483 CALLAWAY PLANT UNIT 1 UNION ELECTRIC CO. FACILITY OPERATING LICENSE NPF-30 BLIND SPECIMEN TEST RESULTS PO Box 620 Fulton, MO 65251 On June 25, 2010, Ameren received unexpected blind specimen results from Clinical Reference Laboratory.
This specimen originated from lot 7418-190-37.2 which was manufactured to be positive for Marijuana metabolite.
A specimen from the aforementioned lot was also sent to Quest Diagnostics in Lenexa, KS. The expected results were returned from Quest on 6-27-2010; however, the quantitative value reported was 31 nglmllower than the Certificate of Analysis reference lab value. Neither of these laboratories has received actual employee specimens between January 1 and July 15, 2010. Later on June 25, 2010, Ameren was notified that lot 7418-190-37.2 had been quarantined by the supplier, Duo Research; the quarantine was based on study #2 as described in the attached report. In response to the enacted quarantine, Ameren replaced all second quarter blind specimens that originated from lot 7418-190-37.2 with new blind specimens to meet the second quarter blind requirements of 10CFR26. All replacement blind specimens were returned with the expected results as compared to the certificate of analysis values. Based on this third occurrence within a year of unexpected THC results, Ameren has initiated further investigation into the cause of these issues. A new lot of specimens have been ordered from the existing supplier as well as a new supplier and those specimens will be received, stored and shipped under varying environmental conditions to determine whether factors other than the obvious quality of lot 7418-190-37.2 contributed to these events. Results of this testing should be completed by the end of August, 2010. a subsidiary of Ameren Corporation ULNRC-05720 July 26, 2010 Page 2 Ameren's previous report, ULNRC-05710 dated June 4,2010, documents an unexpected blind specimen result from Clinical Reference Laboratory for Marijuana.
This specimen also originated from the now quarantined lot 7418-190-37.2.
In accordance with 10CFR26.719(c), enclosed is the documentation of investigative finding and the corrective actions taken by Duo Research.
Please contact Anna Lee at 573/676-4435 if any additional action is needed as a result of this information.
This letter does not contain new commitments.
Sincerely, Luke H. Graessle Director, Operations Support CSP/nls Enclosures ULNRC-05720 July 26, 2010 Page 3 cc: Mr. Elmo E. Collins, Jr. Regional Administrator U. S. Nuclear Regulatory Commission Region IV 612 E . Lamar Blvd., Suite 400 Arlington, TX 76011-4125 Senior Resident Inspector Callaway Resident Office U. S. Nuclear Regulatory Commission 8201 NRC Road Steedman, MO 65077 Mr. Mohan C. Thadani (2 copies) Senior Project Manager, Callaway Plant Office of Nuclear Reactor Regulation U. S. Nuclear Regulatory Commission Mail Stop 0-8G 14 Washington, DC 20555-2738 ULNRC-05720 July 26, 2010 Page 4 Index and send hardcopy to QA File A160.0761 Hardcopy:
Certrec Corporation 4200 South Hulen, Suite 422 Fort Worth, TX 76109 (Certrec receives ALL attachments as long as they are non-safeguards and may be publicly disclosed. ) Electronic distribution for the following can be made via Other Situations ULNRe Distribution:
A. C. Heflin F. M. Diya L. S. Sandbothe C. O. Reasoner III S. P. Banker S. A. Maglio S. L. Gallagher T. L. Woodward (NSRB) T. B. Elwood Ms. Diane M. Hooper (WCNOC) Mr. Tim Hope (Luminant Power) Mr. Ron Barnes (APS) Mr. Tom Baldwin (PG&E) Mr. Wayne Harrison (STPNOC) Ms. Linda Conklin (SCE) Mr. John O'Neill (Pillsbury Winthrop Shaw Pittman LLP) Missouri Public Service Commission
\W WAmeren UE AmerenUE Callaway Plant AAFFD 1 0-0024 July 20, 2010 Mrs. Anna Lee Supervisor Access AuthorizationIFitness for Duty . Ameren DE Callaway Plant P.O. Box 620 Fulton, MO 65251 RE: Investigation of Blind performance testing error POBox 620 Fulton, Mo. 65251 I have received and reviewed the investigative report submitted by Duo Research.
I am in agreement with the statements made apd the corrective actions that are planned. I have also received and reviewed AmerenUE's report of findings and planned corrective actions. As MRO, I am satisfied that the appropriate actions are being taken to resolve the issue. If any further questions arise please do not hesitate to give me a call at 573-676-4301.
William P. Cravens M.D. Callaway Plant Medical Review Officer cc: A160.0001 Attachment 1 to ULNRC-05720 Review performed by Dr. William Cravens Page 1 of 1 a subsilliary of Ameren Corporation INVESTIGATION REPORT on Blind Performance Test Samples Objective:
The licensee shall investigate any unsatisfaotory performance testing result. A record shall be made of the investigative findings and the corrective action taken by the laboratory.
The licensee shall send the dooument to the NRC as a report of the unsatisfactory performance testing incident within 30 days.
References:
10 CFR 26 Subpart G, §26.168(g)
(3) Observation:
Ameren submitted blind quality control samples meeting the requirements of §26.168(g)
(3), i.e., positive challenge samples, oontaining to three laboratories.
Two of the laboratories reported the sample as positive, the third laboratory reported the sample as negative.
The three laboratories, Quest, CRL and Toxicology Laboratory, provided the screening and subsequent GC/MS oonfirmation results. Findings:
- 1. The samples were sent frozen to AmerenUE Callaway Plant by Duo Research Inc. on April 6, 2010. The samples were packaged in individual Nalgene bottles, which had remained frozen from the time of production.
Quest and Clinical Reference Laboratories (CRL) received samples from the same lot and Toxioology Laboratory from another lot for which an acceptable result was received.
For the lot in question, a reference analysis was conducted by MedTox Laboratories on October 13, 2009, which obtained a concentration of 95 ng/mL. The six month reanalysis by MedTox was conducted on April 8 with a concentration of 82 ng/mL. The acceptable range for the *THeA Positive Challenge sample type is 75 to 100 ng/mL, i.e., in the 150% to 200% range of the 50 ng/mL screening cutoff, as per the NRC regulations.
It is the usual procedure for Ameren staff to thaw the sample bottles, transfer the samples into the speoimen vials provided by the laboratories, and submit the samples appearing as real specimens to the two laboratories.
They were submitted to the laboratories June 24, 2010. 2. A negative results was reported by CRL and a positive result was reported by Quest. The results and review of the information provided by each laboratory are presented below. Attaclnnent 2 to ULNRC-05720 Investigative Report provided by Duo Research Page 10f3 Page 1 Investigation Report Page 2 3. Clinical Reference Laboratories (CRL) , Lenexa, KS This laboratory reported the sample as negative.
The sample was received on June 25, 2010. The laboratory reported the result as negative that day. CRL provided the following information:
The screening result was negative with a result of 22 compared to that of 50 for the cutoff calibrator using DR! screening reagents.
CRL, in a follow up investigation, conducted a GC/MS analysis with a result of 34 ng/mL. . 4. Quest Diagnostics, Lenexa, KS This laboratory received the sample on June 25 and reported it as positive on June 27. The sample screened positive and was confirmed using GC/MS, with a result of 51 ng/mL. Discussion:
The intent of the NRC requirement in §26.168(g)
(3) to submit blind quality control samples in the positive range of 150% to 200% above the outoff. The quality control samples submitted to the reference laboratory, MedTox, and by Ameren to the two laboratories were subjected to somewhat different handling and Shipping.
The reference sample was sent frozen to MedTox, which had to thaw the sample and conduct the analysis.
This occurred within a day of its receipt. The samples were also sent frozen to Ameren and stored frozen until they were thawed and prepared for shipment as blinds to the three laboratories.
Although it is known that the THC-9-acid metabolite is not totally stable, a one day differenoe in testing does not support a stability problem as the quantitative results are all within the range of variability allowed for quantitation.
In order to investigate what factors could account for the differences, a study was conducted to determine the cause of these differences.
study 1: Four samples, from the same lot of THC-9-acid that was discussed above, were sent frozen to Ameren. Ameren prepared the four samples for submission to the four laboratories in the same manner. Three.went to the Ameren contract laboratories:
Toxicology Laboratories, Quest and CRL. The fourth was sent to MedTox, the reference laboratory used by Duo Research, using a custody form and air bill that is routinely used to submit quality control samples blind to MedTox. MedTox reported the sample as negative.
In a follow-up investigation, the sample gave a screening result of -58 compared to the value of -89 for the 37.5 ng/mL control. The cutoff control of 50 ng/mL is set a zero. The other three samples were reported as positive, with the following results: Toxicology Laboratory 49 ng/mL f Quest 58 ng/roL, and CRL 51 ng/mL. It appears that the difference between the reference value of 82 ng/mL by MedTox in April and the results from these samples from the same lot may be related to the differences in handling and shipment to the laboratories.
The samples in this lot are deteriorating somewhere in the process. Attachment 2 to ULNRC-05720 Investigative Report provided by Duo Research Page 2 of3 Investigation Report Page 3 This is an unusual occurrence.
Records were reviewed for the results on other samples for this lot that were submitted to MedTox by a Duo Research client. The client is located in Minnesota and has its workplace specimens picked up by a MedTox courier, delivered to the laboratory that day and often tested within hours of receipt. The client receives the samples frozen, like Ameren,. and thaws them the morning of preparation.
One was prepared December 3, 2009, received by the laboratory that day and eventually reported negative.
Duo Research investigated the result. MedTox reported that it screened negative and followed up by conducting a confirmation.
The result was 47. Another sample from this lot was processed and received at MedTox on April 16, 2010. It was reported positive with a quantitative value of 77 ng/mL. The previous result appeared to be an anomaly as no other sample from this lot had been reported as negative.
Study 2: To further investigate the erratic phenomenon of this sample lot, a study was conducted to gauge the effect of shipping the samples frozen or thawed to a reference laboratory.
Two frozen sample of the THC-9-acid from this lot were removed from the storage freezer. One was kept frozen and sent to ElSohly Laboratories frozen and the other sent thawed. Both samples were shipped overnight.
The results were 69.S ng/mL for the sample that was received frozen and 68 ng/mL for the liquid sample.
Conclusion:
It is clear from this last study that shipping the samples from this lot frozen or thawed did not make a significant difference in the results. From the earlier study with the samples submitted by Ameren, there did appear to be some additional loss of the analyte although not that much. The +/-20% range of the average of the three results obtained by Ameren is 52.7 +/-10.5, or a range of 42.2 to 63.2 ng/mL. The higher range is not that different from the results received from ElSohly Laboratories.
However, these results do clearly indicate that this lot of THC-9-acid has become unstable and will be destroyed.
A new lot of THC-9-acid positive challenge samples was prepared and 20 samples sent to Ameren to investigate if any possible contribution to sample handling and processing is a factor. Prepared for:
UE Callaway Plant by Duo Research Inc. July 15, Attachment 2 to ULNRC-05720 Investigative Report provided by Duo Research Page 3 of3 2010